ANTHEM price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- ANTHEM
- MB Code
- MBEQU4937
- ISIN
- INE0CZ201020
- BSE code
- 544449
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 610.94 Cr
- Net profit
- 189.76 Cr
- EPS
- 3.34
- YoY revenue
- +26.44%
Company documents
10 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for ANTHEM
Dividend of ₹2.00 per share
Ex-date corporate action
Anthem Biosciences debuted strongly, with shares rising 28% above the IPO price of ₹570, reflecting positive investor sentiment and stron…
Deven Choksey recommends "Subscribe" to the Anthem Biosciences Ltd IPO in its report dated July 14, 2025.
Anthem Biosciences shares debuted at a 27% premium over their IPO price on Monday. The public offer raised Rs 3,395 crore.
Anthem Biosciences debuted on July 21 at ₹723.05 on NSE, up 26.85% from its IPO price, raising ₹3,395.79 crore with a subscription of 67.…
Anthem Biosciences shares surged 28% on their market debut, closing with a market capitalization of Rs 41,017 crore.
Anthem Biosciences shares surged over 27% on NSE and BSE, trading at Rs. 730.70, up 1.05% from the listing price, marking a notable incre…
Anthem Biosciences shares debuted on the stock exchanges with a 27% premium over the IPO price. Investors are considering whether to buy,…
Price returns
Historical performance
Technicals
Indicator consensus